Abstract P3-12-15: Clinical characteristics, treatment patterns, and survival outcomes in women with early triple-negative (TN) or hormone receptor-positive/human epidermal growth factor receptor-2 negative (HR+/HER2−) breast cancer (BC) in the real-world (RW) setting

Anagha Gogate,Amanda Crosbie,Catherine Davis,Trong Kim Le,Rolee Das,Ying Zhang

doi:10.1158/1538-7445.sabcs21-p3-12-15

Abstract P3-12-15: Clinical characteristics, treatment patterns, and survival outcomes in women with early triple-negative (TN) or hormone receptor-positive/human epidermal growth factor receptor-2 negative (HR+/HER2−) breast cancer (BC) in the real-world (RW) setting

Anagha Gogate, Amanda Crosbie + Show 4 more

https://doi.org/10.1158/1538-7445.sabcs21-p3-12-15

Copy DOI

Journal: Cancer Research

Publication Date: Feb 15, 2022

Affiliation: Bristol-Myers Squibb (United States)

#Neoadjuvant Therapy #Survival Outcomes In Women + Show 8 more

Abstract
Full-Text
Similar Papers

Abstract

Abstract P3-12-15: Clinical characteristics, treatment patterns, and survival outcomes in women with early triple-negative (TN) or hormone receptor-positive/human epidermal growth factor receptor-2 negative (HR+/HER2−) breast cancer (BC) in the real-world (RW) setting

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title

Journal

Date

Author

View more papers

More From: Cancer Research

Paper Title

Journal

Date

Author

View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.